TAKTakeda Pharmaceutical Company Limited
$18.73+24% 1Y
$18.73
$13.2352 weeks$19.05
TAK in its own filings
Nothing in TAK's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
377
Events found in the filings · across 704 filings · the record starts in 2017
- Hard flags
- none
Hard flags
- Most recent filing
- Sep 14, 2026
Most recent filing · Form 6-K
- Record starts
- Jan 18, 2017
Record starts · the earliest filing Ryufin holds for this name
Details›
- SEC comment-letter activity10 occurrences
- 2019-11-12
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
opening the record…
Drug Manufacturers, Specialty & Generic
Ranks #15 of 41 by RyuScore